Institutional investors hold a majority ownership of AMGN through the 82.73% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CANDRIAM LUXEMBOURG SA Bought 700.3 Thousand shares of Amgen
NORDEA INVESTMENT MANAGEMENT AB ... Bought 537.1 Thousand shares of Amgen
STATE STREET GLOBAL ADVISORS LTD... Bought 236.0 Thousand shares of Amgen